deltaDOT ramps up Peregrine production:
This article was originally published in Clinica
UK molecular imaging company deltaDOT is looking to expand production of its Peregrine high throughput capillary electrophoresis systems, with the £3m ($6m) it raised in a recent round of financing. The funding came from a consortium of investors led by FF&P Private Equity, and which includes Imperial Innovations, NPI Ventures, Sitka Health Fund VCT and London Technology Fund. The capital will also go towards growing deltaDOT's international sales and marketing infrastructure, particularly in the US, and developing its pipeline products.